Anti-vascular endothelial growth factor receptor in colorectal cancer: A review

In recent years, the treatment of metastatic colorectal cancer (mCRC) has dramatically changed thanks to the advent of new drugs called molecular targeted therapies such as anti-vascular endothelial growth factor (anti-VEGF) and anti-epidermal growth factor (anti-EGFR). Bevacizumab, aflibercept and...

Full description

Bibliographic Details
Main Authors: Alfredo Colombo, Concetta Maria Porretto
Format: Article
Language:English
Published: Society of Gastrointestinal Intervention 2023-07-01
Series:International Journal of Gastrointestinal Intervention
Subjects:
Online Access:https://www.ijgii.org/journal/view.html?doi=10.18528/ijgii230011